Media-OutReach Newswire Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease
Media-OutReach Newswire Citi Raises Fosun International’s Target Price to HK$6.5 and Reiterates "Buy" Rating
Media-OutReach Newswire Kenanga Futures Launches "Futures Awaken" to Help Traders Navigate Market Volatility
Media-OutReach Newswire Huatai Securities' H1 2025 Net Profit Surges Over 40%, Fueled by Tech Leadership and Global Growth